title: Erdheim-Chester disease harboring the BRAF V600E mutation.
authors.affiliation: Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Victoria, Australia, 8006. Piers.Blombery@petermac.org
authors.forename: Piers
authors.initials: P
authors.lastname: Blombery
authors.forename: Stephen Q
authors.initials: SQ
authors.lastname: Wong
authors.forename: Stephen
authors.initials: S
authors.lastname: Lade
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001549:Benzamides; D015415:Biomarkers / Q000378:metabolism; D031249:Erdheim-Chester Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D018698:Glutamic Acid; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010879:Piperazines / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D011743:Pyrimidines / Q000008:administration & dosage; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism; D014633:Valine
chemical_list: D001549:Benzamides; D015415:Biomarkers; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D018698:Glutamic Acid; D000068877:Imatinib Mesylate; D011239:Prednisolone; D020797:Receptor, Platelet-Derived Growth Factor beta; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D014633:Valine